References
- Nowak J. Role of HLA in hematopoietic SCT. Bone Marrow Transplant 2008; 42(Suppl 2): S71—S76.
- Ruggeri L, Capanni M, Urbani E et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002; 295: 2097–2100.
- Ruggeri L, Capanni M, Mancusi A et al. Natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplan-tation. Int J Hematol 2005; 81: 13–17.
- Raulet DH, Held W. Natural killer cell receptors: the offs and onsof NK cell recognition. Cell 1995; 82: 697–700.
- Ljunggren HG, Malmberg U. Prospects for the use of NK cells inimmunotherapy of human cancer. Nat Rev Immunol 2007; 7: 329–339.
- Willemze R, Rodrigues CA, Labopin M et al. KIR-ligand incompatibility in the graft-versus-host direction improves out-comes after umbilical cord blood transplantation for acute leukemia. Leukemia 2009; 23: 492–500.
- Giebel S, Locatelli F, Lamparelli T et al. Survival advantage withKIR ligand incompatibility in hematopoietic stem cell transplanta-tion from unrelated donors. Blood 2003; 102: 814–819.
- Perez-Martinez A, Leung W, Munoz E et al. KIR-HLA receptor-ligand mismatch associated with a graft-versus-tumor effect in haploidentical stem cell transplantation for pediatric metastatic solid tumors. Pediatr Blood Cancer 2009; 53: 120–124.
- Verheyden S, Schots R, Duquet W, Demanet C. A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after related HLA-identical hematopoietic stem cell transplantation. Leukemia 2005; 19: 1446–1451.
- Brunstein CG, Wagner JE, Weisdorf DJ et al. Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity. Blood 2009; 113: 5628–5634.
- Uhrberg M, Valiante NM, Shum BP et al. Human diversity in killer cell inhibitory receptor genes. Immunity 1997; 7: 753–763.
- Trowsdale J. Genetic and functional relationships between MHC and NK receptor genes. Immunity 2001; 15: 363–374.
- Yabe T, Matsuo K, Hirayasu K et al. Donor killer immunoglo-bulin-like receptor (KIR) genotype-patient cognate KIR ligand combination and antithymocyte globulin preadministration are critical factors in outcome of HLA-C-KIR ligand-mismatched T cell-replete unrelated bone marrow transplantation. Biol Blood Marrow Transplant 2008; 14: 75–87.
- Cooley S, Trachtenberg E, Bergemann TL et al. Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogen-ous leukemia. Blood 2009; 113: 726–732.
- Zhang Y, Ohyashiki JH, Shimizu N, Ohyashiki K. Aberrant expression of NK cell receptors in Epstein-Barr virus-positive yö T-cell lymphoproliferative disorders. Hematology 2009; 15: 43–47.
- Shilling HG, McQueen KL, Cheng NW, Shizuru JA, Negrin RS, Parham P. Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation. Blood 2003; 101: 3730–3740.
- Leung W, Iyengar R, Turner V et al. Determinants of antileukemia effects of allogeneic NK cells. J Immunol 2004; 172: 644–650.
- Leung W, Iyengar R, Triplett B et al. Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors. J Immunol 2005; 174: 6540–6545.
- Yawata M, Yawata N, McQueen KL et al. Predominance of group A KIR haplotypes in Japanese associated with diverse NK cell repertoires of KIR expression. Immunogenetics 2002; 54: 543–550.
- Goodridge JP, Lathbury Li, John E, Charles AK, Christiansen FT, Witt CS. The genotype of the NK cell receptor, KIR2DL4, influences INFgamma secretion by decidual natural killer cells. Mol Hum Reprod 2009; 15: 489–497.
- Denis L, Gagne K, Gueglio B et al. NK-KIR transcript kinetics correlate with acute graft-versus-host disease occurrence after allogeneic bone marrow transplantation. Hum Immunol 2005; 66: 447–459.
- Tanaka J, Mori A, Ohta S et al. Expression of HLA-C-specific natural killer cell receptors (CD158a and CD158b) on peripheral blood mononuclear cells after allogeneic bone marrow transplan-tation. Br J Haematol 2000; 108: 778–783.
- Foley B, De Santis D, Lathbury L, Christiansen F, Witt C. KIR2DS1-mediated activation overrides NKG2A-mediated inhi-bition in HLA-C C2-negative individuals. Int Immunol 2008; 20: 555–563.
- Triplett BM, Horwitz EM, Iyengar R et al. Effects of activating NK cell receptor expression and NK cell reconstitution on the outcomes of unrelated donor hematopoietic cell transplantation for hematologic malignancies. Leukemia 2009; 23: 1278–1287.